Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-Valent Pneumococcal Conjugate Vaccine

This study has been completed.

Study NCT00345358 Information provided by GlaxoSmithKline

First Received: June 27, 2006 Last Updated: May 21, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2007
Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)